-
公开(公告)号:ZA200304270B
公开(公告)日:2004-08-30
申请号:ZA200304270
申请日:2003-05-30
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , HASVOLD LISA A , LI TOMGMEI , MANTEI ROBERT A , SHAM HING L , TONG YUNSONG , WANG LE , WANG WEIBO , GWALTNEY STEPHEN L II , LI QUN , LIN NAN-HORNG , ROCKWAY TODD W , SULLIVAN GERARD M , WANG GARY T , WANG XILU
IPC: A61K20060101 , A61P20060101 , C07D20060101 , C07D , A61K , A61P
-
公开(公告)号:HK1058031A1
公开(公告)日:2004-04-30
申请号:HK03108723
申请日:2003-11-28
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL A
IPC: C07C20060101 , A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D20060101 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107
-
公开(公告)号:CA2479362A1
公开(公告)日:2003-10-02
申请号:CA2479362
申请日:2003-03-14
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , WANG XILU , PARK CHEOL-MIN
IPC: C07D295/20 , A61K31/4418 , A61K31/4422 , A61K31/495 , A61K31/5377 , A61P25/18 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/06 , A61P43/00 , C07D211/16 , C07D211/18 , C07D211/26 , C07D211/58 , C07D211/82 , C07D211/90 , C07D295/215
Abstract: Compounds having the formula (I) are apoptosis promoters. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:PE20020687A1
公开(公告)日:2002-08-03
申请号:PE2001001198
申请日:2001-11-29
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , GWALTNEY II STEPHEN L , LI QUN , LIN NAN-HORNG , ROCKWAY TODD W , SULLIVAN GERARD M , WANG GARY T , WANG XILU , WANG WEIBO , WANG LE , TONG YUNSONG , SHAM HING L , MANTEI ROBERT A , LI TONGMEI , HASVOLD LISA A
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12 , C07D401/01
Abstract: SE REFIERE A IMIDAZOLES Y TIAZOLES DE FORMULA I DONDE E ES UN ANILLO CARBOCICLICO AROMATICO O NO AROMATICO DE CINCO, SEIS O SIETE MIEMBROS DONDE ENTRE 0-3 ATOMOS DE CARBONO ESTAN REEMPLAZADOS POR NITROGENO; F Y G SON C Y N CON LA SALVEDAD DE QUE CUANDO UNO DE F Y G ES N EL OTRO ES C; L1 Y L2 SON ALQUENILENO, ALQUINILENO, O, NR9, C(O), S, ENTRE OTROS; X ES S, NR7; R1 ES ARILO, ARILALQUILO, HETEROCICLO, (HETEROCICLO)ALQUILO; R2 ES H, ALCOXI, ALQUILO, AMINO, AMINOALQUILO, CIANO, CIANOALQUILO, ENTRE OTROS; R3 ES ARILO, HETEROCICLO Y CICLOALQUILO; R4-R6 SON H, NR9C(O), C(N)NR9, ALCANOILO, ALQUENILO, ENTRE OTROS; R7 ES H, ALQUILO, ARILO, CICLOALQUILO, ENTRE OTROS; R9 ES H, ALCOXIALQUILO, ALQUILO, AMIDOALQUILO, ENTRE OTROS; R12 ES H, ALCOXI, ALQUILO, ENTRE OTROS; m, n, p, q SON 0-4. SON COMPUESTOS PREFERIDOS 4-(((6-CLORO-2-(3-CLOROFENIL)-3-PIRIDINIL)METOXI)(1-METIL-1H-IMIDAZOL-5-IL)METIL)BENZONITRILO, 4-(((2-(3-CLOROFENIL)-6-METIL-3-PIRIDINIL)METOXI)(1-METIL-1H-IMIDAZOL-5-IL)METIL)BENZONITRILO, ENTRE OTROS. LOS COMPUESTOS MENCIONADOS SON INHIBIDORES DE LA FARNESIL TRANSFERASA Y SON UTILES PARA EL TRATAMIENTO DE TUMORES
-
35.
公开(公告)号:CA2747170C
公开(公告)日:2017-07-18
申请号:CA2747170
申请日:2009-12-17
Applicant: ABBOTT LAB , GENENTECH INC , THE WALTER AND ELIZA HALL INST OF MEDICAL RES
Inventor: BAELL JONATHAN BAYLDON , BUI CHINH THIEN , COLMAN PETER , CZABOTAR PETER , DUDLEY DANETTE A , FAIRBROTHER WAYNE J , FLYGARE JOHN A , LESSENE GUILLAUME LAURENT , NDUBAKU CHUDI , NIKOLAKOPOULOS GEORGE , SLEEBS BRAD EDMUND , SMITH BRIAN JOHN , WATSON KEITH GEOFFREY , ELMORE STEVEN W , HASVOLD LISA A , PETROS ANDREW M , SOUERS ANDREW J , TAO ZHI-FU , WANG LE , WANG XILU , DESHAYES KURT
IPC: C07D417/14 , A61K31/4725 , A61P35/00 , C07D455/04 , C07D487/04 , C07D495/04 , C07D513/04
Abstract: In one aspect, the present invention provides for a com-pound of Formula I; in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compo-sitions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-ex-pression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-X L proteins.
-
公开(公告)号:DOP2012000153A
公开(公告)日:2017-04-30
申请号:DO2012000153
申请日:2012-06-01
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , WANG LE , PARK CHEOL-MIN , TAO ZHI-FU , DING HONG , HASVOLD LISA , HEXAMER LAURA , MCCLELLAN WILLIAM J , PARK CHANG H , PETROS ANDREW M , SULLIVAN GERARD M , WANG GARY T , WENDT MICHAEL D , MANTEI ROBERT A , HANSEN TODD M , DOHERTY GEORGE A , KUNZER AARON
IPC: A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04
Abstract: Compuestos de Fórmula I derivados de sulfonamida, por ejemplo, N-({5-cloro-6-[(4,4-difluorociclohexil)metoxi]piridin-3-il}sulfonil)-4-(4-{[2-(4-clorofenil)-4,4-dimetilciclohex-1-en-1-il]metil}piperazin-1-il)-2-(1H-indazol-4-iloxi)benzamida, que inhiben la actividad de las proteínas anti-apoptóticas Bcl- 2 o Bcl-XL y composiciones que contienen dichos compuestos, los cuales sirven para preparer un medicamento útil en el tratamiento de enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2, por ejemplo, cáncer de vejiga, cáncer de cerebro, cáncer de mamas, cáncer de médula ósea, cáncer cervical, leucemia linfocítica crónica, cáncer colorrectal, cancer de esófago, cáncer hepatocelular, leucemia linfoblástica, linfoma folicular, una malignidad linfoide originada en células T o células B, melanoma, leucemia mielógena, mieloma, cáncer oral, cáncer de ovarios, cáncer de pulmón de células no pequeñas, cáncer de próstata, cáncer de pulmón de células pequeñas o cáncer de bazo, entre otras.
-
公开(公告)号:CA2682354C
公开(公告)日:2016-12-13
申请号:CA2682354
申请日:2008-04-16
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , SONG XIAOHONG , DING HONG , TAO ZHI-FU , KUNZER AARON R , MADAR DAVID , SOUERS ANDREW J , ELMORE STEVEN W , PARK CHEOL-MIN , WANG XILU
IPC: C07D209/42 , A61K31/404 , A61K31/405 , A61P35/00 , C07D403/04
Abstract: Compounds of formula (I) which inhibit the activity of anti-apoptotic Mcl-1 protein, compositins containing the compounds, and methods of treating diseases involving overexpressed or unregulated Mcl-1 protein are disclosed.
-
公开(公告)号:CA2759182C
公开(公告)日:2016-06-07
申请号:CA2759182
申请日:2010-05-26
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL , MANTEI ROBERT , HANSEN TODD M
IPC: C07D471/04 , A61K31/437 , A61P35/00 , A61P35/02
Abstract: Compounds of Formulas I and II which inhibit the activity of anti-apoptocic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein. Formulas I and II are as follow: (see formula I) and (see formula II) wherein the definitions for A1, B1, D1, E1, G1, L1, Y1, Z1, Z1A, Z2, Z2A and Z3 are as defined in the specification.
-
公开(公告)号:CA2609202C
公开(公告)日:2014-12-23
申请号:CA2609202
申请日:2006-05-17
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN , LYNCH CHRISTOPHER , WANG XILU
IPC: C07D273/00 , A61K31/395 , A61P35/00 , C07D413/12
Abstract: Compounds of formula (I), in which B1 and X1 are together alkylene which is unsubstituted or substituted with =O and having one CH2 moiety unreplaced or replaced with CH=CH, O, NH or N(alkyl), which inhibit the activity of antiapoptotic Bcl-2 family protein members, compositions containing the compounds and methods of treating diseases during which are expressed one or more than one of an anti-apoptotic family protein member are disclosed.
-
40.
公开(公告)号:CO6480950A2
公开(公告)日:2012-07-16
申请号:CO11178424
申请日:2011-12-26
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE , ELMORE STEVEN W , HASVOLD LISA A , HEXAMER LAURA , KUNZER AARON R , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D , MANTEI ROBERT A , HANSEN TODD M
IPC: C07D471/00
Abstract: Compuestos que inhiben la actividad de proteínas anti-apoptóticas BcI-2, composiciones que contienen a dichos compuestos y métodos de tratamiento de enfermedades durante cuyo transcurso hay expresión de la proteína anti-apoptótica BcI-2.
-
-
-
-
-
-
-
-
-